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Background/Purpose: Infection is a severe complication after total knee replacement (TKR) and creates
great disability. We reviewed our 11-year experience in the management of TKR infection and its
outcome.
Methods: Patients who had TKR infection from 2001 to 2011 in our hospital were reviewed
retrospectively.
Results: A total of 727 TKRs were performed from 2001 to 2011 and 12 cases of post-TKR infection were
identiﬁed (1.65%). In the acute group, two patients had debridement with exchange of liner and four
patients had a two-stage operation. No re-infection was noted. For the chronic presentation group, four
out of six patients had a two-stage operation and none of them suffered from re-infection. The remaining
two patients had debridement and exchange of liner and both had re-infection with a two-stage oper-
ation performed afterwards. One patient had no re-infection thereafter. Another patient was on long-
term suppressive antibiotics because of the failure to eradicate the infection.
Conclusion: The incidence of TKR infection in our hospital is comparable to the reported incidence in the
literature. This study also showed that a two-stage operation has a higher success rate in the manage-
ment of chronic TKR infection.
中 文 摘 要
引言: 全膝關節置換術後感染是一種嚴重的併發症，並能引致巨大的殘障。我們回顧過去11年治療此併發症
的經驗及其臨床結果。
材料與方法: 我們回顧分析了由2001年至2011年，在本院患有全膝關節置換術後感染的病人。
結果: 本院在2001年至2011年期間施行了727宗全膝關節置換術, 當中12病例有術後感染 (1.65%)。在急性術
後感染組別的病人中, 2名病人接受了清創及塑膠假體更換手術, 4名病人接受了兩階段全膝關節重換手術,他們
在術後均沒有再受感染。在6名慢性術後感染组別的病人中, 4名病人接受了兩階段全膝關節重換手術而在術
後並沒有再受感染，其餘2名病人接受了清創及塑膠假體更換手術，但因感染情況未能控制而需要接受兩階
段全膝關節重換手術。其後1人的感染痊癒但另1人因感染未能根除而需長期服用抑制抗生素。
結論: 本院全膝關節置換術後感染的發病率與其他同類研究相近。本研究亦顯示在慢性全膝關節置換術後感
染患者施行兩階段全膝關節重換手術會有較高的成功率。Introduction
Periprosthetic infection is one of the most devastating and
dreaded complications of total knee replacement (TKR). The quoted
incidences in the literature are 1e3%1 and 2.5%2 with contemporary
infection preventive measures. Treatments of these infections are.
sociation and Hong Kong College of Orthoften costly and involve prolonged hospital stays, therefore effective
management is important. In this study, we aim at reviewing the
incidence of periprosthetic infection in total knee arthroplasty, their
outcomes, and the success rate of revision surgeries in our hospital.Methods
We retrieved all patients who underwent TKRs in our hospital
from 2001 to 2011. The ﬁles for patients who were diagnosed withopaedic Surgeons. Published by Elsevier (Singapore) Pte Ltd. All rights reserved.
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M.S.-H. Tse et al. / Journal of Orthopaedics, Trauma and Rehabilitation 18 (2014) 79e8280periprosthetic infection were retrieved. Their management plans
and treatment outcomes were analysed. We diagnosed peri-
prosthetic infection based on the criteria suggested by Parvizi et al,1
which involved satisfying one of the following criteria: (1) presence
of an abscess or sinus tract communicating with the joint space; (2)
positive preoperative culture of aspirate on solid culture medium;
or (3) two or more positive intraoperative cultures of the same
organism, or one positive culture in conjunction with the presence
of gross intracapsular purulence or abnormal histological ﬁndings.
Debridement with liner exchange and two-stage revision sur-
gery were the two forms of management that we employed to treat
our patients with periprosthetic infection. For the debridement and
liner exchange, we performed thorough debridement and replaced
the polyethylene insert in a one-stage procedure. Antibiotics were
continued for at least 6 weeks afterwards. For the two-stage revi-
sion, the ﬁrst stage involved removal of the implant with its cement
and thorough debridement was performed. A self-moulded antibi-
otics-loaded cement spacer was then inserted. The antibiotics we
used were tobramycin 1 g per 40 g cement with the addition of 1 g
vancomycin per 40 g cement if the culture revealed methicillin-
resistant Staphylococcus aureus (MRSA), methicillin-resistant coag-
ulase-negative Staphylococcus, or if a Gram stain showed Gram-
positive cocci in clusters. Systemic antibiotics according to the cul-
ture sensitivity were then continued for a minimum of 6 weeks
(range6e14weeks,meanduration9weeks). The second stageof the
procedure involved implantation of a new prosthesisdthis was
performed a minimum of 8 weeks after the ﬁrst stage of the pro-
cedure when the inﬂammatory markers were normalised. The
infection was considered eradicated when a patient underwent no
subsequent operations for the infectious organism after reimplan-
tation. Patients who maintained on long-term suppressive antibi-
otics due to positive intraoperative wound culture in second stage
operation were also considered as failure to eradicate infection.
Results
A total of 727 TKRs were performed between 2001 and 2011, and
12 cases of periprosthetic infections were identiﬁed. All the pa-
tients had elevated white cells and neutrophils in their knee aspi-
rations, high erythrocyte sedimentation rate, and high C-reactive
protein, as well as positive culture from the knee aspirations
(Table 1). The incidence of infection of TKRs in our hospital was
1.65%.
We identiﬁed a few risk factors in our patients. Two patients had
rheumatoid arthritis, one had diabetes mellitus, one had a history
of recurrent lower limb cellulitis, and one had a history of septic
knee arthritis. In all cases, the causative organism could be iden-
tiﬁed. Three patients had MRSA, two had methicillin-resistant
coagulase-negative Staphylococcus, one had methicillin-sensitive
coagulase-negative Staphylococcus, three had Streptococcus aga-
lactiae, and three had Streptococcus Group G.
The patients were classiﬁed into early postoperative, acute
haematogenous, and late chronic infections based on the Tsu-
kayama classiﬁcation.3 Early postoperative infection is deﬁned as
infection occurring < 4 weeks after the operation. Acute haema-
togenous infection is signiﬁed by acute onset of symptoms in a
previously well-functioning joint. Late chronic infection is present
when infection occurs  4 weeks after the index operation. In our
study, one patient had early postoperative infection, ﬁve had acute
haematogenous infection, and six had late chronic infections.
For patients who had early postoperative infection and acute
haematogenous infections, two of them had debridement and liner
exchange and four of them had a two-stage revision done. None of
the patients had re-infection with a mean follow-up time of 12.7
months (range 8e20 months).
Table 2
Results of management of late chronic infections
Infection eradicated/number
of patients (%)
Two-stage revision 4/4 (100)
Debridement and liner exchange 0/2 (0)
Two-stage revision after failed
debridement and liner exchange
1/2 (50)
Figure 1. A dynamic cement spacer was inserted at the ﬁrst stage operation.
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had a two-stage revision and no re-infection was noted on follow
up. The other two patients with late chronic infections (both had
symptoms of knee pain and swelling for a duration of 7weeks and 8
weeks, respectively) had debridement and liner exchange and both
failed to control the infection. A two-stage revision was performed
in these two patients afterwards and one of them had no subse-
quent re-infection. However, another patient was found to have
two positive intraoperative cultures of MRSA (the same organism of
the infected TKR) taken during the second stage reimplantation
procedure. This patient required long-term suppressive antibiotic
treatment and was considered as failure to eradicate the infection.
Themean follow-up duration in patients with late chronic infection
was 39 months (range 15e89 months). There was a 100% success
rate for primary two-stage procedures, 0% for simple debridement
and liner exchange, and 50% for the salvage two-stage procedure
(Table 2). The success rate of the primary two-stage operation in
chronic TKR infection was higher than debridement and exchange
of liner with prosthesis retention (p ¼ 0.067) with statistical sig-
niﬁcance. The success rates of eradicating infections with respect to
various organisms are listed in Table 3.
In the two-stage revision procedure, we employed a self-
moulded dynamic spacer at the ﬁrst stage of the operation
(Figure 1). The mean range of movement after insertion of the
articulating spacer was 7.5e59 and the mean range of movement
after the second stage reimplantation was 0e92.5.Discussion
The management of an infected TKR is one of the greatest
challenges for arthroplasty surgeons. Fortunately, the incidence of
infection of TKRs in our hospital was 1.65%, which is comparable to
ﬁgures quoted in other literatures.1,2
Treatment options included debridement with retention of the
prosthesis, reimplantation arthroplasty (one- and two-stage pro-
cedures), permanent prosthesis removal (resection arthroplasty,
arthrodesis), long-term suppressive antibiotic therapy, and ampu-
tation. The success rates for the different procedures varied
tremendously depending on patient selection, microbiology,
duration of symptoms, infection types, and length of follow-up.
However, the gold standard is still the delayed two-stageTable 3
Success rate of infection eradication in different organisms
Number of
patients
Debridement and liner exchan
Infection eradicated/number o
MRSA 3 1/3 (33.3)
Coagulase ve Staphylococcus,
methicillin-resistant
2 0
Coagulase ve Staphylococcus,
methicillin-sensitive
1 0
Streptococcus agalactiae 3 1/1 (100)
Streptococcus Group G 3 3/3 (100)
MRSA ¼ methicillin-resistant Staphylococcus aureus; ve ¼ negative.reimplantation protocol. Insall et al4 and Windsor et al5 reported
their experience of two-stage reimplantation with long-term
follow-up. The infection eradication rate was 97.4%.
Poor prognostic factors are long duration of infection and
symptoms, multidrug resistant (MDR) organisms, Gram-negative
organisms, staphylococcal infection, and negative culture. The
prevalence of MDR organisms has increased greatly. Infected TKRs
with resistant organisms are difﬁcult to treat and a high failure rate
was reported.6 However, a recent study of the two-stage reimplan-
tation protocol showed similar successful eradication ratesd91.3%
for sensitive organisms and 91.2% for resistant organisms.7
Open debridement with prosthesis retention is the least inva-
sive method that may eradicate infection of prosthetic joints. It
enables patients to regain function rapidly and is therefore an
appealing surgical strategy. Mont et al8 reported a high success rate
for acute haematogenous and 100% for early postoperative TKR
infections without removal of the prosthesis. Segawa et al3 re-
ported a very poor result with this surgical treatment for late
chronic TKR infection. A few studies concluded that a shorter
duration of symptoms was associated with a more favourable
treatment outcome in patients who underwent debridement with
prosthesis retention.8e10 Although this procedure was not as suc-
cessful as a delayed exchange procedure in other studies,11,12 careful
patient selection is likely to yield favourable results comparablege Two-stage procedure Combined
f patients (%) Infection eradicated/number of patients (%)
1/2 (50) 2/3 (66.7)
2/2 (100) 2/2 (100)
1/1 (100) 1/1 (100)
2/2 (100) 3/3 (100)
0 3/3 (100)
M.S.-H. Tse et al. / Journal of Orthopaedics, Trauma and Rehabilitation 18 (2014) 79e8282with more invasive strategies, as suggested by Laffer et al,13 Zim-
merli and Ochsner,14 and Zimmerli et al.15 The treatment algorithm
developed by Zimmerli et al15 for treatment with retention of the
prosthesis helps selection of patients who fulﬁlled all selection
criteria (early postoperative or acute haematogenous infection,
duration of clinical symptoms < 3 weeks, stable implant with intact
soft tissue, and microorganism susceptible to antibiotics with ac-
tivity against surface-adhering bacteria) for successful debride-
ment with prosthesis retention. However, staphylococcal infection
is found to be an independent predictor of failure of treatment
involving irrigation and debridement with implant
retention.11,16e22 It is also found that MRSA is poorly eradicated
with this treatment.20,22 This was also shown in our studydwe had
a lower success rate of infection eradication with MRSA, especially
when debridement and liner exchange was performed (33.3% after
debridement and liner exchange, 66.7% overall success rate after
debridement and liner exchange and the two-stage procedure).
Streptococcal infections, which have historically been well treated
with irrigation and debridement with implant retention, had an
eradication rate (65%) that was comparable with that of all other
organisms (71%).18
In our study, we have noted that debridement with liner ex-
change has a much higher success rate in patients with early
postoperative or acute haematogenous infections, when
compared with patients with late chronic infections. This ﬁnding
is comparable to studies done by Segawa et al3 and Chiu and
Chen.23 With the two-stage procedure, we had a 100% success
rate when it was done in a primary setting and 83.3% success rate
when both primary and secondary procedures were included.
This is in accordance with studies done by Westrich et al7 and
Gooding et al24 that had success rates of 91.3% and 87.8%,
respectively.
The drawback of the debridement and exchange of liner is the
lower eradication rate following two-stage reimplantation in pa-
tients who have undergone previous irrigation and debridement
compared with patients treated directly with two-stage reim-
plantation.19 This was exempliﬁed by our review where a lower
success rate (50%) of eradicating infection was noted when two-
stage procedures were performed on patients who had failed ﬁrst
debridement and liner exchange.
Prostalac is an antibiotics-loaded cement with a small metal-
on-polythene articular surface; it is used to maintain alignment,
stability, and range of movement in knees after the ﬁrst stage of a
procedure.25 In our hospital, we have been using a self-moulded
articulating spacer made from antibiotics-loaded cement. Tobra-
mycin was commonly chosen because it had a broad spectrum of
susceptible organisms and an effective bactericidal level intra-
articularly with negligible serum levels after 24 hours.26 Static
cement spacers were not used because they did not allow pa-
tients to move their knees and required cast immobilisation
before the second stage of the operation. They also carried a risk
of dislodgement and bone erosion.27 We found that our self-
moulded articulating spacer made from antibiotics-loaded
cement was a lower-cost alternative to Prostalac. It also gave a
reasonable range of knee movement and facilitated the rehabili-
tation after the second stage of the procedure for our patients.
The limitations of our study were that is was retrospective and
only a small number of patients could be studied because of the
low incidence of infected TKR in our centre. There was no stand-
ardised treatment protocol for infected TKR. The follow-up dura-
tion was relatively short when compared with other similar
studies.
We recommend a two-stage revision operation for patients with
late chronic infection because it was shown to have a higher success
rate in eradicating infection.Conﬂicts of interest
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